{
  "trial_id": "NCT00918723",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, Eastern Cooperative Oncology Group (ECOG) performance status, Rai stage, Ann Arbor stage, absolute neutrophil count (ANC), platelet count, hemoglobin level, prothrombin time (PT), international normalized ratio (INR), partial thromboplastin time (PTT), potassium level, magnesium level, serum creatinine, creatinine clearance, serum total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, presence of cytopenias, history of prior malignancy, history of active hemolysis, history of active obstructive hydronephrosis, history of significant systemic illness, history of heart disease, history of congenital long QT syndrome, history of human immunodeficiency virus (HIV) infection, pregnancy status, history of brain or leptomeningeal involvement by malignancy, history of prior treatment with histone deacetylases (HDAC) inhibitors, history of prior stem cell or bone marrow transplant, history of active hepatitis B or other active infections, history of participation in a study with an investigational compound or device within 30 days.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Rai stage at the time of diagnosis",
          "Rai stage"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Rai stage at the time of treatment",
        "Time to treatment",
        "B symptoms",
        "del 17p (Cytogenetics/immunophenotypic characteristics)",
        "del 11q (Cytogenetics/immunophenotypic characteristics)",
        "Trisomy 12 (Cytogenetics/immunophenotypic characteristics)",
        "del 13q (Cytogenetics/immunophenotypic characteristics)",
        "Normal cytogenetic (Cytogenetics/immunophenotypic characteristics)",
        "Other chromosomal abnormalities (Cytogenetics/immunophenotypic characteristics)",
        "High CD38 expression (> 30%) (Cytogenetics/immunophenotypic characteristics)",
        "High ZAP-70 (> 20%) (Cytogenetics/immunophenotypic characteristics)"
      ],
      "remaining_candidate_features": [
        "race",
        "Ann Arbor stage",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin level",
        "prothrombin time (PT)",
        "international normalized ratio (INR)",
        "partial thromboplastin time (PTT)",
        "potassium level",
        "magnesium level",
        "serum creatinine",
        "creatinine clearance",
        "serum total bilirubin",
        "aspartate aminotransferase (AST)",
        "alanine aminotransferase (ALT)",
        "alkaline phosphatase",
        "presence of cytopenias",
        "history of prior malignancy",
        "history of active hemolysis",
        "history of active obstructive hydronephrosis",
        "history of significant systemic illness",
        "history of heart disease",
        "history of congenital long QT syndrome",
        "history of human immunodeficiency virus (HIV) infection",
        "pregnancy status",
        "history of brain or leptomeningeal involvement by malignancy",
        "history of prior treatment with histone deacetylases (HDAC) inhibitors",
        "history of prior stem cell or bone marrow transplant",
        "history of active hepatitis B or other active infections",
        "history of participation in a study with an investigational compound or device within 30 days."
      ]
    },
    "processed-gen-response": "Age, sex, race, Eastern Cooperative Oncology Group (ECOG) performance status, Rai stage, Ann Arbor stage, absolute neutrophil count (ANC), platelet count, hemoglobin level, prothrombin time (PT), international normalized ratio (INR), partial thromboplastin time (PTT), potassium level, magnesium level, serum creatinine, creatinine clearance, serum total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, presence of cytopenias, history of prior malignancy, history of active hemolysis, history of active obstructive hydronephrosis, history of significant systemic illness, history of heart disease, history of congenital long QT syndrome, history of human immunodeficiency virus (HIV) infection, pregnancy status, history of brain or leptomeningeal involvement by malignancy, history of prior treatment with histone deacetylases (HDAC) inhibitors, history of prior stem cell or bone marrow transplant, history of active hepatitis B or other active infections, history of participation in a study with an investigational compound or device within 30 days."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count (ANC), Platelet Count, Hemoglobin Level, Serum Creatinine, Serum Total Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Potassium Level, Magnesium Level, Stage of Disease, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Absolute Neutrophil Count (ANC)",
          "Absolute Neutrophil Count (ANC)"
        ],
        [
          "Platelet Count",
          "Platelet Count"
        ],
        [
          "Hemoglobin Level",
          "Hemoglobin Level"
        ],
        [
          "Serum Creatinine",
          "Serum Creatinine"
        ],
        [
          "Serum Total Bilirubin",
          "Serum Total Bilirubin"
        ],
        [
          "Aspartate Aminotransferase (AST)",
          "Aspartate Aminotransferase (AST)"
        ],
        [
          "Alanine Aminotransferase (ALT)",
          "Alanine Aminotransferase (ALT)"
        ],
        [
          "Alkaline Phosphatase",
          "Alkaline Phosphatase"
        ],
        [
          "Potassium Level",
          "Potassium Level"
        ],
        [
          "Magnesium Level",
          "Magnesium Level"
        ],
        [
          "Stage of Disease",
          "Rai stage at the time of treatment"
        ]
      ],
      "remaining_reference_features": [
        "Rai stage at the time of diagnosis",
        "Time to treatment",
        "B symptoms",
        "del 17p (Cytogenetics/immunophenotypic characteristics)",
        "del 11q (Cytogenetics/immunophenotypic characteristics)",
        "Trisomy 12 (Cytogenetics/immunophenotypic characteristics)",
        "del 13q (Cytogenetics/immunophenotypic characteristics)",
        "Normal cytogenetic (Cytogenetics/immunophenotypic characteristics)",
        "Other chromosomal abnormalities (Cytogenetics/immunophenotypic characteristics)",
        "High CD38 expression (> 30%) (Cytogenetics/immunophenotypic characteristics)",
        "High ZAP-70 (> 20%) (Cytogenetics/immunophenotypic characteristics)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count (ANC), Platelet Count, Hemoglobin Level, Serum Creatinine, Serum Total Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Potassium Level, Magnesium Level, Stage of Disease"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Rai Stage, Disease Activity, Hemoglobin, Absolute Neutrophil Count, Platelets, Serum Creatinine, Serum Total Bilirubin, AST, ALT, Alkaline Phosphatase.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Rai stage at the time of treatment",
          "Rai Stage"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Hemoglobin",
          "Hemoglobin"
        ],
        [
          "Absolute Neutrophil Count",
          "Absolute Neutrophil Count"
        ],
        [
          "Platelets",
          "Platelets"
        ],
        [
          "Serum Creatinine",
          "Serum Creatinine"
        ],
        [
          "Serum Total Bilirubin",
          "Serum Total Bilirubin"
        ],
        [
          "AST",
          "AST"
        ],
        [
          "ALT",
          "ALT"
        ],
        [
          "Alkaline Phosphatase",
          "Alkaline Phosphatase"
        ]
      ],
      "remaining_reference_features": [
        "Rai stage at the time of diagnosis",
        "Time to treatment",
        "B symptoms",
        "del 17p (Cytogenetics/immunophenotypic characteristics)",
        "del 11q (Cytogenetics/immunophenotypic characteristics)",
        "Trisomy 12 (Cytogenetics/immunophenotypic characteristics)",
        "del 13q (Cytogenetics/immunophenotypic characteristics)",
        "Normal cytogenetic (Cytogenetics/immunophenotypic characteristics)",
        "Other chromosomal abnormalities (Cytogenetics/immunophenotypic characteristics)",
        "High CD38 expression (> 30%) (Cytogenetics/immunophenotypic characteristics)",
        "High ZAP-70 (> 20%) (Cytogenetics/immunophenotypic characteristics)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Disease Activity"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Rai Stage, Disease Activity, Hemoglobin, Absolute Neutrophil Count, Platelets, Serum Creatinine, Serum Total Bilirubin, AST, ALT, Alkaline Phosphatase."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, Rai stage, Ann Arbor stage, CD20 status, ANC, platelet count, hemoglobin, serum creatinine, serum total bilirubin, AST, ALT, alkaline phosphatase, potassium level, magnesium level, prothrombin time or INR, PTT.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Rai stage at the time of treatment",
          "Rai stage"
        ],
        [
          "ECOG performance status",
          "ECOG performance status"
        ],
        [
          "Absolute Neutrophil Count (ANC)",
          "ANC"
        ],
        [
          "Platelets",
          "platelet count"
        ],
        [
          "Hemoglobin",
          "hemoglobin"
        ],
        [
          "Serum creatinine",
          "serum creatinine"
        ],
        [
          "Serum total bilirubin",
          "serum total bilirubin"
        ],
        [
          "Aspartate aminotransferase (AST)",
          "AST"
        ],
        [
          "Alanine aminotransferase (ALT)",
          "ALT"
        ],
        [
          "Alkaline phosphatase",
          "alkaline phosphatase"
        ],
        [
          "Potassium level",
          "potassium level"
        ],
        [
          "Magnesium level",
          "magnesium level"
        ],
        [
          "Prothrombin time or international normalized ratio (INR)",
          "prothrombin time or INR"
        ],
        [
          "Partial thromboplastin time (PTT)",
          "PTT"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Rai stage at the time of diagnosis",
        "Time to treatment",
        "B symptoms",
        "del 17p (Cytogenetics/immunophenotypic characteristics)",
        "del 11q (Cytogenetics/immunophenotypic characteristics)",
        "Trisomy 12 (Cytogenetics/immunophenotypic characteristics)",
        "del 13q (Cytogenetics/immunophenotypic characteristics)",
        "Normal cytogenetic (Cytogenetics/immunophenotypic characteristics)",
        "Other chromosomal abnormalities (Cytogenetics/immunophenotypic characteristics)",
        "High CD38 expression (> 30%) (Cytogenetics/immunophenotypic characteristics)",
        "High ZAP-70 (> 20%) (Cytogenetics/immunophenotypic characteristics)"
      ],
      "remaining_candidate_features": [
        "race",
        "Ann Arbor stage",
        "CD20 status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, Rai stage, Ann Arbor stage, CD20 status, ANC, platelet count, hemoglobin, serum creatinine, serum total bilirubin, AST, ALT, alkaline phosphatase, potassium level, magnesium level, prothrombin time or INR, PTT."
  }
}